Purchase Order 75N92024P00256

<p>The Department of Health and Human Services National Institutes of Health National Heart Lung and Blood Institute awarded a Firm Fixed Price Purchase Order to Proteogenix, a for-profit manufacturer, to provide phage-display library screening services to develop in vivo gene therapy. The contract has a potential value of $46,260.00 and a completion date of April 21, 2025. The contract was awarded on April 22, 2024 and does not have a set-aside designation.</p>

The National Heart Lung and Blood Institute (NHLBI), part of the National Institutes of Health (NIH), awarded a $10,620 firm fixed price purchase order to Proteogenix, a for-profit manufacturer of biotechnology products and services. The contract provides additional laboratory screening services to support the development of novel gene therapy by the NHLBI's Center for Molecular Therapeutics and Bioanalytics (CMTB). This award is not associated with a larger contract vehicle and does not have...

<p>This is a Firm Fixed Price contract awarded by the National Heart Lung and Blood Institute, a civilian agency, to Protein Foundry, LLC, a small business, for the &quot;Therapeutic Delivery of ADP-Ribosylarginine Hydrolase, SBIR Topic 91, Phase I&quot; with a ceiling value of $250,000.00. The contract has a total small business set-aside designation. The contract was awarded on September 15, 2015 and is set to be completed by March 14, 2017.</p>

This is a firm-fixed-price purchase order contract awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Cancer Institute to the prime contractor Aldevron, L.L.C., a for-profit limited liability company that manufactures biologics. The contract is for the production and purification of custom DNA plasmids, specifically 600 mg of pM766 gp160 V1, 40 mg of pSW M766 gp120 V1, and 600 mg of SIV p57 Gag custom plasmids, to support ongoing research...

<p>This $23,991.00 firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency within the U.S. Department of Health and Human Services, to Protein Biosolutions Inc. on May 8, 2014. The contract is for AMBIS # 1678920 SEQUENCING services, with a period of performance ending on June 20, 2014. The contract was not set aside for any specific business type.</p>

This is a $12,560.96 firm fixed price purchase order awarded to Life Technologies Corporation, a manufacturer of scientific instruments, reagents, and consumables, by the National Heart Lung and Blood Institute (NHLBI) on March 31, 2025. The contract supports the NHLBI lab's requirement for antibodies and cell culture media to assess antigens on the surface within human neutrophils by flow cytometry, and has a completion date of July 1, 2025. The award is not associated with a set-aside program....

<p>This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian agency, to Bioproximity LLC, a for-profit limited liability company, for global proteomic profiling sample preparation and data services. The contract has a ceiling value of $89,100.00 and an ultimate completion date of August 2, 2016. This contract award is not associated with a larger vehicle and does not have a set-aside designation.</p>

This is a $199,828 Firm Fixed Price contract awarded by the National Cancer Institute (NCI), a component of the Department of Health and Human Services, to A&amp;G Pharmaceutical, Inc. (doing business as Precision Antibody) for the development of &quot;TECHNOLOGY GENERATED ANTI-PEPTIDE CAPTURE REAGENTS FOR AFFINITY ENRICHED PROTEOMIC STUDIES.&quot; The contract has a performance period ending on July 24, 2014 and was awarded on September 25, 2013. Precision Antibody is a for-profit...

This is a firm fixed price purchase order awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute on Aging to A&amp;G Pharmaceutical, Inc. (doing business as Precision Antibody), a for-profit manufacturer of goods. The $14,630.25 contract is for the development of monoclonal antibodies to support biomedical research. Precision Antibody has provided similar services to HHS components like the National Cancer Institute and Department of...

<p>This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID) to Glycobiotech GMBH, a for-profit organization, for the delivery of BIOLOGICALS/ANTIBODIES. The contract has a ceiling value of $9,806.58 and an ultimate completion date of November 27, 2015. The contract was awarded on November 13, 2015 and does not have a set-aside designation.</p>